Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

President’s Message

Welcome back after a bit of a break from the newsletter thanks to a busy twelve months, with several key events alongside the usual schedule of Australian and international scientific meetings, including completion of accrual to NITRO, the  initiation of BR31, our first Preceptorship and two idea generation workshops. The next 6 to 12 months promises to be equally busy and we are keen to hear from other members who would like to be involved.

A key focus of ALTG over the last year has been to build up our trial portfolio.  The idea generation workshops were particularly helpful for this and there are plans to continue this activity. There are several trials currently under discussion with industry sponsors and we would expect at least one or two of these to go forward. Likewise the Preceptorship was a great way to engage with trainees and the ALTG is working with the Lung Foundation to plan a second event in 2016.

ALTG now has an early lung cancer interest group, bringing together clinicians, scientists and researchers focused on diagnosing and treating lung cancer when it is most curable. Low-radiation dose CT lung scan screening in smokers at high risk of cancer has already been implemented in some countries and we need to work on how this can most effectively employed in Australia.

Karen has moved on to another job with the Lung Foundation, after many years supporting ALTG. Without effective central administrative support, co-operative trials groups such as ALTG couldn’t exist. Karen – A VERY BIG THANK YOU FOR ALL YOUR DEDICATION AND HARD WORK.

And hello to Ros, whose appointment is the result of the ALTG’s development to this point – Ros will be helping to maintain and drive the group’s current portfolio of activities as well as actively seeking opportunities for continued growth and development.

The international lung cancer trials group initiative (Thoracic Alliance for Cancer Trials, TACT) is an excellent example of the ALTG’s success to date – spearheading the steering committee to establish this exciting global initiative is a great demonstration of the group’s enthusiasm and efforts.